EN DE
Watch Sanginita Chemicals Limited for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Sanginita Chemicals Limited (SANGINITA) fair value: what the stock is really worth

As of Nov 12, 2026: fair value (intrinsic value) of Sanginita Chemicals Limited stock ₹63.24, price ₹51.54, upside +22.7%, quality 38 out of 100. Rating: undervalued. Calculated from audited financials with 7 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Basic Materials IN · ISIN INE753W01010

SC Sanginita Chemicals Limited logo Thin data Nov 15, 2026

Sanginita Chemicals Limited

SANGINITA · NSE

Rising price, but only slightly cheap (19% below fair value) and weak company: meets 1 of 3 rules.

Get notified free when this changes
Fair value ₹63.24 · Undervalued 
Rising price (uptrend) 
Low debt 
Generates free cash flow 
Revenue last quarter 45% below a year ago. 
Changed on Oct 30: ₹74.58 → ₹63.24 
Quality 38/100 
Weak Growth (revenue 5y +1.4 %/yr in INR) 
Loss-making · -13.6% net margin (TTM) 
Trails peers (3/11) 
Narrow moat 12/100
Thin data 
⟳ Cyclical⚠ Dilution
Watch Sanginita Chemicals Limited for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

₹75.39 ₹8.79 Fair Value ₹63.24 Jul 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 15, 2026.

How to read this chart

60‑month range ₹8.79 – ₹75.39 · fair‑value band ₹47.57 – ₹83.08 · the ₹51.54 price screens below the ₹63.24 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 15, 2026.

Follow Sanginita Chemicals in your weekly email

Every Wednesday you see whether Sanginita Chemicals is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Sanginita Chemicals Limited manufactures and sells cuprous chloride, cupric chloride, and copper sulphate in India and internationally. It also offers copper phthalocyanine blue.

Show moreShow less

The company's products are used in dyes and pigments, paint, pharmaceuticals, electroplating, metal extraction and ink, carbon paper, and PVC pipe coating industries. It also exports its products. The company was founded in 2003 and is based in Gandhinagar, India.

Stock analysis

Sanginita Chemicals Limited (SANGINITA) currently trades at ₹51.54, while our model-based Fair Value estimate is ₹63.24, implying the stock looks roughly 19% undervalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of ₹40.68 per share, and 0 of the 7 models we run sit above the ₹51.54 price.

Bear case: the Asset-Based group reads lowest at ₹8.42, and 7 of the 7 models stay below the price. Data coverage for this calculation is low.

Scenario range: ₹47.57 (bear) to ₹83.08 (bull), the price of ₹51.54 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 38/100 (below-average quality), in the Basic Materials sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

Sanginita Chemicals Limited reported revenue of ₹1.8B in FY2026 versus ₹2.0B in FY2022, a compound −2.8%/yr. Reported net income was −₹96.9M in FY2026.

Key figures

Market cap ₹2.0B (≈ $21.7M) Micro · P/S ratio 1.23 · EPS (TTM) ₹−7.20 · Net margin −13.6% · Return on equity −18.9% · Return on assets (EBIT) 0.5% (5-year average) · Operating margin −44.7% · Revenue (TTM) ₹1.6B.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 12 out of 100 (medium confidence).

What moves the price

The share trades about 32% below its 52-week high and 431% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at −28% fair-value upside, at 23%, SANGINITA screens cheaper than that median.

Fair Value models

Bear ₹47.57 Fair Value ₹63.24 Bull ₹83.08
Price ₹51.54 · Upside +22.7%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF ₹28.35 ₹36.27 ₹45.46 81
Growth DCF ₹28.79 ₹36.08 ₹44.20 79
5Y Revenue Exit ₹27.98 ₹40.44 ₹55.63 72
All 7 models by family
DCF Models
FCF DCF ₹28.35 ₹36.27 ₹45.46 81
5Y Revenue Exit ₹27.98 ₹40.44 ₹55.63 72
10Y Revenue Exit ₹27.25 ₹37.20 ₹48.87 67
Multiples
EV/Revenue ₹27.55 ₹40.68 ₹53.81 52
Asset-Based
NCAV (Graham) ₹5.55 ₹8.42 ₹10.52 53
Growth DCF
Growth DCF ₹28.79 ₹36.08 ₹44.20 79
Rev-Margin DCF ₹27.98 ₹40.98 ₹54.79 72

The fair value above starts from this blend and is adjusted for a cyclical trough year.

Open the full fair value analysis →

Quality Score breakdown

Overall quality 38/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 20
How much profit the company makes from its sales and capital
Quality Growth 16
Are margins and returns getting better?
Cashflow 59
Do the profits arrive as real cash?
Financial strength 70
Debt, balance sheet and risk of trouble
Investment 92
Does it invest with discipline instead of growing at any price?
Low Volatility 62
How calm the share price moves, does not count
Price momentum 80
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 82
Distance to the 52-week high, does not count
New shares 0
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 26/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−23.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+1.4%
Start year 2021 (pandemic). Over 10 years: +2.0% a year
Revenue growth 14 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.6%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
2.0% (2021) → −4.6% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
not computed

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+11.7%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (India: IMF forecast 4.1% a year to 2030, 4.7% from 2016 to 2025) that is about +7.2% a year for the price.

Watch SANGINITA, get fair value alerts →

Compare Sanginita Chemicals Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Chemicals · 361 stocks

Beats the industry median on 3/10 measures
Overall it trails its industry peers.
Valuation
Quality Score 38 · Bottom 25%
Fair Value upside +22.7% · Top 25%
Profitability
Return on assets −12.6% · Bottom 25%
Net margin (12 months) −13.6% · Bottom 25%
Operating margin (12 months) −44.7% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) −44.9% · Bottom 25%
Balance sheet
Debt / equity 0.07× · Below median

Valuation Multiplesvs Chemicals median · lower = cheaper

P/B 4.40× · Priciest 25%
P/S (12 months) 1.31× · Pricier than median
Price / free cash flow (fiscal year) 15.3× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)64 · sector 11
FUTURE (revenue growth)0 · sector 73
PAST (return on equity)0 · sector 24
HEALTH (low debt)97 · sector 94
DIVIDEND (yield)0 · sector 32

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Chemicals stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
LG Chem, Ltd 051910 227,000 KRW 587,755 KRW +159% vs SANGINITA
Dow Inc DOW $33.04 $41.88 +27% vs SANGINITA
Hengli Petrochemical Co 600346 ¥16.40 ¥19.26 +17% vs SANGINITA
Ningxia Baofeng Energy Group 600989 ¥20.64 ¥22.31 +8% vs SANGINITA
BASF SE BAS €53.74 €38.46 −28% vs SANGINITA
Zhejiang Juhua Co 600160 ¥30.41 ¥19.31 −37% vs SANGINITA
Formosa Chemicals & Fibre Corporation 1326 69.80 TWD 35.56 TWD −49% vs SANGINITA
Ganfeng Lithium Group 002460 ¥34.89 ¥15.80 −55% vs SANGINITA
Rongsheng Petrochemical Co 002493 ¥11.40 ¥4.15 −64% vs SANGINITA
Zangge Mining Company 000408 ¥63.66 ¥17.47 −73% vs SANGINITA

Explore undervalued stocks

More undervalued Basic Materials stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Sanginita Chemicals Limited: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Sanginita Chemicals Limited Fair Value". https://www.fairvalue-calculator.com/stock/SANGINITA

Frequently asked questions

Is Sanginita Chemicals Limited (SANGINITA) overvalued or undervalued?
As of Nov 15, 2026, our model estimates a fair value of ₹63.24 versus a price of ₹51.54, about +23% upside (undervalued).
What is the fair value of SANGINITA?
Our model-based fair value for Sanginita Chemicals Limited is ₹63.24 (as of Nov 15, 2026), built from audited fundamentals. The current price: ₹51.54.
What is the quality score of SANGINITA?
Sanginita Chemicals Limited has a Quality Score of 38/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Sanginita Chemicals Limited (SANGINITA)?
Our model-based price target is the fair value of ₹63.24 (as of Nov 15, 2026) from 7 valuation models. Cautious scenario ₹47.57, optimistic scenario ₹83.08. It is a calculation from audited fundamentals, not an analyst target.
What is the Sanginita Chemicals Limited stock forecast for 2026?
Our models put fair value at ₹63.24, about +23% upside versus a price of ₹51.54 (undervalued). Cautious scenario ₹47.57, optimistic scenario ₹83.08. The calculation is refreshed regularly with new filings.
What is the revenue of Sanginita Chemicals Limited (SANGINITA)?
Sanginita Chemicals Limited reported trailing-twelve-month revenue of about ₹1.6B (latest available figure, as of Nov 15, 2026).
What growth is priced into Sanginita Chemicals Limited (SANGINITA)?
For today's price to be fair in a discounted-cash-flow model, Sanginita Chemicals Limited would have to grow free cash flow by 11.7 % per year for five years (discount rate 12.4 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew 1.4 % per year. As of Nov 15, 2026.
What discount rate (WACC) does the fair value of SANGINITA use?
Our models discount Sanginita Chemicals Limited at 12.4 %: a base by market capitalisation (nano), country premium for India. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Sanginita Chemicals Limited that is +11.7 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (12.4 %) and the same formula as our fair value.
How much growth has Sanginita Chemicals Limited (SANGINITA) delivered so far?
Over the past 5 years revenue at Sanginita Chemicals Limited grew 1.4 % a year. The price currently implies free-cash-flow growth of +11.7 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Sanginita Chemicals Limited (SANGINITA) growing?
The median revenue growth in the sector is +11.6 % a year. That is the yardstick for the growth priced into Sanginita Chemicals Limited (+11.7 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Sanginita Chemicals Limited (SANGINITA)?
The free-cash-flow yield on the price is 6.53 %: that much free cash flow Sanginita Chemicals Limited produces per unit of market value. When it exceeds the discount rate of our models (12.4 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Sanginita Chemicals Limited (SANGINITA)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Sanginita Chemicals Limited it is ₹63.24 per share (as of Nov 15, 2026), against a price of ₹51.54. It is the blended result of 7 valuation models in 4 families (DCF Models, Multiples, Asset-Based, Growth DCF).
Is Sanginita Chemicals Limited stock overvalued or undervalued in 2026?
As of Nov 15, 2026, SANGINITA trades below its calculated fair value: price ₹51.54, fair value ₹63.24, a gap of about +23% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of SANGINITA?
No. The price is what the market pays today (₹51.54); the fair value is what the company's own numbers justify (₹63.24). For Sanginita Chemicals Limited the two are ₹11.70 per share apart. That gap is exactly why we show both numbers side by side.
How much is Sanginita Chemicals Limited worth?
The market values Sanginita Chemicals Limited at about ₹2.0B (market capitalisation, as of Nov 15, 2026). Per share that is ₹51.54; our models calculate a fair value of ₹63.24 per share.
What do the bullish and bearish scenarios say about SANGINITA?
Our models span a range for Sanginita Chemicals Limited: cautious scenario ₹47.57, base ₹63.24, optimistic ₹83.08 per share (as of Nov 15, 2026, price ₹51.54). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Sanginita Chemicals Limited (SANGINITA)?
Balance-sheet figures for Sanginita Chemicals Limited (as of Nov 15, 2026): return on equity −18.9%, debt of 0.07 per unit of equity. They feed the Quality Score of 38/100, which measures business quality independently of the share price.
How far is SANGINITA from its 52-week high?
Sanginita Chemicals Limited trades at ₹51.54, about 32% below its 52-week high of ₹75.39 and 431% above the low of ₹9.71 (as of Nov 12, 2026). Distance from the high says nothing about value: that is what the fair value of ₹63.24 is for.
Which stocks are comparable to Sanginita Chemicals Limited?
From the same area (Basic Materials) we also value BASF SE, Dow Inc, Ningxia Baofeng Energy Group, Rongsheng Petrochemical Co, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Sanginita Chemicals Limited stock attractive at the current price?
The data as of Nov 15, 2026: price ₹51.54, calculated fair value ₹63.24 (+23%), Quality Score 38/100, from 7 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of SANGINITA calculated?
We run Sanginita Chemicals Limited through 7 models from 4 families: DCF Models, Multiples, Asset-Based, Growth DCF. Every model gets the same audited fundamentals; the fair value of ₹63.24 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5% above its aggregate fair value. Sanginita Chemicals Limited currently trades 19% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Sanginita Chemicals Limited (SANGINITA)?
The closing price on Nov 12, 2026 was ₹51.54. Our model-based fair value is ₹63.24, about +23% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Sanginita Chemicals Limited right now?
Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual. The price sits in the lower half of our model range, the side with the larger margin of safety. Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.
Where does the earnings growth of Sanginita Chemicals Limited (SANGINITA) come from?
Earnings per share at Sanginita Chemicals Limited fell 8.1 % a year from 2015 to 2026. Broken into its drivers: revenue per share +0.4 %, EBIT margin −6.6 %, tax rate +1.1 %, residual (interest, one-offs) −3.1 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Sanginita Chemicals Limited

How large is the market capitalisation of Sanginita Chemicals Limited (SANGINITA)?
The market capitalisation of Sanginita Chemicals Limited is ₹2.0B (≈ $21.7M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Sanginita Chemicals Limited (SANGINITA)?
The price-to-sales ratio of Sanginita Chemicals Limited is 1.23 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Sanginita Chemicals Limited (SANGINITA)?
Earnings per share at Sanginita Chemicals Limited are ₹−7.20. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Sanginita Chemicals Limited (SANGINITA)?
The net margin of Sanginita Chemicals Limited is −13.6% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Sanginita Chemicals Limited (SANGINITA)?
The return on equity (ROE) of Sanginita Chemicals Limited is −18.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Sanginita Chemicals Limited (SANGINITA)?
On an EBIT basis the return on assets of Sanginita Chemicals Limited is 0.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Sanginita Chemicals Limited (SANGINITA)?
The operating margin of Sanginita Chemicals Limited is −44.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Sanginita Chemicals Limited (SANGINITA)?
Revenue at Sanginita Chemicals Limited is down 44.9% versus a year earlier (3y avg +5.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Sanginita Chemicals Limited (SANGINITA)?
Earnings per share at Sanginita Chemicals Limited are down 66.7% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Sanginita Chemicals Limited (SANGINITA) carry?
The net debt of Sanginita Chemicals Limited is ₹122M (fiscal year 2026, ≈ 0.9 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Sanginita Chemicals Limited in the live analysis

One click puts Sanginita Chemicals Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.